Notably, transforming growth factor-β (TGF-β) released by cancer cells and CAFs is central to immune suppression within the TME, and contributes to tumor immune evasion and poor responses to cancer immunotherapy (10). The gene discussed is TGFB1; the disease is neoplasm.